The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pilot study of HB-200 in patients with HPV16+ head and neck squamous cell carcinoma and detectable TTMV-HPVDNA after definitive therapy.
 
Winston Wong
Consulting or Advisory Role - Merus
Research Funding - BioAtla; Hookipa Biotech
Travel, Accommodations, Expenses - BioAtla
 
Irina Ostrovnaya
No Relationships to Disclose
 
Nadeem Riaz
Honoraria - Oxford university press; PeerView
Consulting or Advisory Role - Mirati Therapeutics; Repare Therapeutics
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Paige.AI; Pfizer; Repare Therapeutics
Travel, Accommodations, Expenses - Varian Medical Systems
 
Eric Sherman
Consulting or Advisory Role - AffyImmune Therapeutics; Natera; UpToDate
Research Funding - AstraZeneca (Inst); Bicara Therapeutics (Inst); Fore Biotherapeutics (Inst); Lilly (Inst); Novartis (Inst); Regeneron (Inst)
 
Lara Dunn
Consulting or Advisory Role - Regeneron
Research Funding - Imvaq Therapeutics; Regeneron; Replimune; Seagan
 
Nancy Lee
Consulting or Advisory Role - J and J; LEO SAB; Merck; Signatera
Research Funding - AstraZeneca (Inst)
 
Richard Wong
No Relationships to Disclose
 
Alan Ho
Honoraria - Horizon CME
Consulting or Advisory Role - AffyImmune Therapeutics; Cantor Fitzgerald; Day One Biopharmaceuticals; GlaxoSmithKline; Immunome; InhibRx; Johnson & Johnson/Janssen; National Cancer Institute; Pyxis; Remix Therapeutics; Rgenta Therapeutics; Takeda
Speakers' Bureau - Miami Cancer Research Center; Mt. Sinai; New York University (NYU); Northwell Health; Physicans' Education Resource
Research Funding - Astellas Pharma; AstraZeneca; Avacta Life Sciences; Ayala Pharmaceuticals; Bayer; Bayer; BioAtla; Bristol-Myers Squibb; Daiichi; Eisai; Genentech/Roche; Hookipa Biotech; Kura Oncology; Merck; Novartis; OncC4; Poseida; Remix Therapeutics; Rgenta; TILT Biotherapeutics; Verastem
Patents, Royalties, Other Intellectual Property - LESIONAL DOSIMETRY METHODS FOR TAILORING TARGETED RADIOTHERAPY IN
Travel, Accommodations, Expenses - Hookipa Pharma; Lepu Biopharma; Remix Therapeutics
Other Relationship - Hookipa Biotech; Lepu Biopharma
(OPTIONAL) Uncompensated Relationships - Alliance for Clinical Trials in Oncology; HPV Cancer Alliance; International Thyroid Oncology Group